The Aspergillus fumigatus mold IgE marker on an allergy panel is a specific test designed to identify allergic reactions to Aspergillus fumigatus, a type of mold that is commonly found both indoors and outdoors. This mold thrives in environments where there is an abundance of decomposing organic matter, such as soil, compost piles, and decaying vegetation, but it can also be present in homes, particularly in damp or poorly ventilated areas like basements, bathrooms, and kitchens. When someone with a sensitivity to Aspergillus fumigatus inhales the mold spores, their immune system may overreact, producing IgE antibodies against these spores. This immune response can lead to allergic symptoms, which might include coughing, wheezing, nasal congestion, and irritation of the eyes and throat. In some cases, exposure to Aspergillus fumigatus can lead to more severe conditions, such as allergic bronchopulmonary aspergillosis, especially in individuals with underlying lung conditions or weakened immune systems. The Aspergillus fumigatus mold IgE test on an allergy panel helps doctors identify this specific allergy, enabling them to provide their patients with targeted advice and treatment options to manage their symptoms and reduce exposure to the allergen.
found in soil, water and air
found in soil, water and air
can cause immune suppression, neurotoxicity, immune toxicity
can cause immune suppression, neurotoxicity, immune toxicity
Calculated ratio of AST to ALT liver enzymes — also called the De Ritis ratio
can cause diarrheal illness (gastroenteritis)
What is Atopobium? Atopobium is a genus of bacteria that resides in the human body, most notably in the gut, oral cavity, and urogenital tract. It is classified as a Gram-positive anaerobic bacterium, meaning it thrives in low-oxygen environments like the gastrointestinal tract. In small, balanced amounts, Atopobium plays a relatively neutral role in the gut microbiome. However, when levels become too high or too low, it can be a signal of microbial imbalance—also known as dysbiosis—that may contribute to various health issues. On the Vibrant Wellness Gut Zoomer panel, Atopobium is measured to help assess your gut’s microbial composition and overall digestive health. This marker is part of a larger picture that helps determine if your gut is in balance—or if certain bacteria are overgrowing or missing.
one of the most widely used herbicides in US
Organophosphate pesticides
Atypical lymphocytes are lymphocytes that have been activated to respond to a viral infection (occasionally a bacterial or parasitic infection). These cells are characterized by their increased size and often the presence of active protein synthesis. Pathologically altered lymphocytes are associated with numerous diseases. A few atypical lymphocytes are probably of little clinical significance. A large number of atypical lymphocytes are often found in viral infections like mononucleosis, cytomegalovirus infections and hepatitis B. Toxoplasmosis, certain bacterial infections, medications, stress and autoimmune diseases can also be accompanied by a larger number of atypical lymphocytes. Atypical lymphocytes can also be observed in patients with several viral infections, such as Epstein-Barr virus infection, cytomegalovirus infection, rubella, Hantavirus infection, viral hepatitis and HIV infection. Several studies have shown that atypical lymphocytes have also been found in the peripheral blood and bronchoalveolar lavage (BAL) samples of COVID-19 patients. It may reflect the disease pathophysiology and provide important information about the diagnosis or prognosis of the disease. References: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrison’s Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Professional; 2008. [Google Scholar] Chong VCL, Lim KGE, Fan BE, Chan SSW, Ong KH, Kuperan P. Reactive lymphocytes in patients with COVID-19. Br J Haematol. 2020;189(5):844. doi: 10.1111/bjh.16690 [PubMed] El Jamal SM, Salib C, Stock A, Uriarte-Haparnas NI, Glicksberg BS, Teruya-Feldstein J, et al. Atypical lymphocyte morphology in SARS-CoV-2 infection. Pathol Res Pract. 2020;216(9):153063. doi: 10.1016/j.prp.2020.153063 [PubMed] Weinberg SE, Behdad A, Ji P. Atypical lymphocytes in peripheral blood of patients with COVID-19. Br J Haematol. 2020;190(1):36–39. doi: 10.1111/bjh.16848 [PubMed] Gelarden I, Nguyen J, Gao J, Chen Q, Morales-Nebreda L, Wunderink R, et al. Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. Hum Pathol. 2021;113:92–103. doi: 10.1016/j.humpath.2021.04.010 [PubMed] The atypical lymphocyte, Wood, Turner A. et al., The American Journal of Medicine, Volume 42, Issue 6, 923 - 936 [L]
can be indicative of various pathological conditions